The Cost of Disorders of the Brain in Europe (CBDE)

On 26 April 2005 the EBC announced the results of a pan-European project it conducted in partnership with Stockholm Health Economics to analyse for the first time the cost of all brain disorders in Europe.

The CDBE study took into account health care costs (including hospital care, ambulatory care, drugs), private and public costs outside the medical sector (including nursing home costs and services or goods for private homes) and indirect costs (including limits on work capability, absenteeism and early retirement). It found that across 28 European countries (the EU plus Iceland, Norway and Switzerland) with a total population of 466 million, 127 million people or 27% are affected by at least one brain disease.

The total cost of brain diseases amounts to €386 billion, or €829 per European inhabitant. The brain diseases included in the study were:

affective disorders anxiety disorders psychotic disorders addiction dementia migraine

stroke multiple sclerosis Parkinson's disease traumatic brain injury brain tumour epilepsy

The full CDBE report is available in the Publications section of this website.

Also available: Acrobat PDF Slide Kit for the EBC “Cost of Disorders of the Brain in Europe”